Moulid Hidayat
YOU?
Author Swipe
View article: Association of ARDS Severity with Non-Invasive Ventilation Duration in COVID-19 Patients
Association of ARDS Severity with Non-Invasive Ventilation Duration in COVID-19 Patients Open
The global spread of Coronavirus disease (COVID-19), worsened by the emergence of new variants such as Delta, has created significant challenges for health systems. One of the severe complications experienced by infected individuals is acu…
View article: Aortic Dissection in Northern Pakistan and Afghanistan and Its Surgical Outcome
Aortic Dissection in Northern Pakistan and Afghanistan and Its Surgical Outcome Open
Background: The aorta can be involved in different pathologies, including congenital, syndromic and acquired disorders, which may need intervention in some form to prevent catastrophe. The purpose of this study is to review the clinical pr…
View article: Indonesian Society of Respirology Position Paper on Lung Cancer Control in Indonesia
Indonesian Society of Respirology Position Paper on Lung Cancer Control in Indonesia Open
Lung cancer is a major health concern in Indonesia due to its increasing prevalence, late-stage diagnosis, younger population, and high mortality. Addressing this issue requires nationwide implementation of comprehensive lung cancer contro…
View article: Brittle bones, fragile heart- a rare case report of osteogenesis imperfecta and mitral valve insufficiency with tragic outcome
Brittle bones, fragile heart- a rare case report of osteogenesis imperfecta and mitral valve insufficiency with tragic outcome Open
Osteogenesis Imperfecta is a rare disease of the connective tissue resulting in bone and tissue fragility. It is characterized by bone fragility, decreased bone mass, and frequent fractures. The range of phenotypic expression varies greatl…
View article: <scp>Anti‐Müllerian</scp> hormone type <scp>II</scp> receptor protein expression in non‐small cell lung cancer and the effect of <scp>AMH</scp>/<scp>AMHR2</scp> signaling on cancer cell proliferation
<span>Anti‐Müllerian</span> hormone type <span>II</span> receptor protein expression in non‐small cell lung cancer and the effect of <span>AMH</span>/<span>AMHR2</span> signaling on cancer cell proliferation Open
Background Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related deaths worldwide despite advances in cancer therapeutics. In several gynecological cancers, anti‐Müllerian hormone receptor type 2 (AMHR2) mediates AMH‐in…
View article: Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer
Clinical potential of SKP2 as diagnostic marker and therapeutic target in small cell lung cancer Open
Although the mechanism underlying SKP2 knockdown-induced growth inhibition differs between RB1-wild-type and -mutant SCLC, SKP2 can be considered a novel therapeutic target for patients with SCLC regardless of the RB1 mutation status. Our …
View article: The Role and Mechanism of Action of Regdanvimab in the Treatment of COVID-19
The Role and Mechanism of Action of Regdanvimab in the Treatment of COVID-19 Open
The neutralizing antibody can be one of the promising treatments to fight the COVID-19 pandemic, based on the previous coronavirus outbreak. Regdanvimab (CT-P59) is a new monoclonal antibody developed by Celltrion that targets the receptor…
View article: ARDS (Acute Respiratory Distress Syndrome) in Pediatric and Adult
ARDS (Acute Respiratory Distress Syndrome) in Pediatric and Adult Open
Acute Respiratory Distress Syndrome (ARDS) is a serious medical condition that occurs when lungs become severely inflamed, which inhibits the ability to take in the oxygen and eliminate carbon dioxide. The purpose of this article is to fin…
View article: Differences in RDW Values of COVID-19 Patients with Pneumonia and Without Pneumonia at RSUM and RSUDP NTB
Differences in RDW Values of COVID-19 Patients with Pneumonia and Without Pneumonia at RSUM and RSUDP NTB Open
Pneumonia coinfection in COVID-19 patients can be an important risk factor for patient mortality. Red blood cell distribution width (RDW) is a predictor that can determine clinical outcomes in patients with respiratory tract infections and…
View article: Supplementary Figure S4 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S4 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S4 shows that MFGE8 regulates the FAK pathway.
View article: Supplementary Figure S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S1 shows that TGFβ1 treatment in MPM cells.
View article: Supplementary Figure Legends from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure Legends from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure Legends
View article: Data from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Data from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that has a low overall survival; however, no significant treatment advances have been made in the past 15 years. Large-scale molecular studies have identified a poor prognos…
View article: Supplementary Figure S5 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S5 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S5 shows role of MFGE8 in MPM.
View article: Supplementary Table S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Table S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Table S1 shows the selected genes with statistically significant changes in transcriptome analysis using two different shRNA constructs.
View article: Supplementary Figure S3 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S3 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S3 shows that LSD1 suppression attenuated the mesenchymal phenotype.
View article: Supplementary Figure Legends from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure Legends from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure Legends
View article: Supplementary Table S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Table S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Table S2 shows the chromatin accessibility with statistically significant changes in genome-wide ATAC-seq.
View article: Data from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Data from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that has a low overall survival; however, no significant treatment advances have been made in the past 15 years. Large-scale molecular studies have identified a poor prognos…
View article: Supplementary Figure S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S2 shows that Snail-1 induces a mesenchymal phenotype in MPM cells.
View article: Supplementary Figure S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S2 shows that Snail-1 induces a mesenchymal phenotype in MPM cells.
View article: Supplementary Figure S6 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S6 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S6 shows that restoring MFGE8 abolishes apoptosis by re-activating the FAK-AKT pathway.
View article: Supplementary Table S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Table S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Table S1 shows the selected genes with statistically significant changes in transcriptome analysis using two different shRNA constructs.
View article: Supplementary Figure S4 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S4 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S4 shows that MFGE8 regulates the FAK pathway.
View article: Supplementary Figure S6 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S6 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S6 shows that restoring MFGE8 abolishes apoptosis by re-activating the FAK-AKT pathway.
View article: Supplementary Figure S3 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S3 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S3 shows that LSD1 suppression attenuated the mesenchymal phenotype.
View article: Supplementary Figure S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S1 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S1 shows that TGFβ1 treatment in MPM cells.
View article: Supplementary Figure S5 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Figure S5 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Figure S5 shows role of MFGE8 in MPM.
View article: Supplementary Table S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1
Supplementary Table S2 from A Novel Therapeutic Strategy Targeting the Mesenchymal Phenotype of Malignant Pleural Mesothelioma by Suppressing LSD1 Open
Supplementary Table S2 shows the chromatin accessibility with statistically significant changes in genome-wide ATAC-seq.
View article: Relationship of Comorbidity and Age to the Severity of Clinical Symptoms of COVID-19 at Mataram University Hospital
Relationship of Comorbidity and Age to the Severity of Clinical Symptoms of COVID-19 at Mataram University Hospital Open
COVID-19 disease is a disease that arises due to infection with the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The purpose of this study was to determine differences in clinical symptoms in elderly and non-elderly patien…